Inflammation and the Host Response to Injury (Burns)

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00257244
Collaborator
(none)
280
4
173
70
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to help improve our understanding of the biology involved in the body's response to serious trauma or burn injury. The host response to trauma and burns is a collection of physiological and pathophysiological processes that depend critically upon the regulation of the human innate immune system, with particular emphasis on the inflammatory component of that system. No single research center or small group of centers has the capacity to delineate the integrated response of this complex biological system, which involves multiple molecular and genetic interactions that vary in time. Our proposal promotes the identification of important dynamic relationships that regulate the integration of this complex biological system, with the expectation that this understanding will ultimately impact the diagnosis, prognosis, and treatment of the hospitalized, severely injured patient.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This large-scale collaborative project provides the means to acquire the necessary new knowledge directly in humans. Knowledge will be acquired using diverse state-of-the-art genomic and proteomic technologies, a highly complex clinical, proteomic, and genomic database, as well as newly-developed, novel analytical tools to probe this complex dataset. Our analytical capabilities at the genomic and proteomic level are now rapidly evolving and our ability to link these genomic and proteomic data to pathways and functional modules will help us more closely link this cellular data to immunological processes and ultimately, to the phenotypic response (i.e., trajectory) in the injured host. As a result, potential interventions, whether through our Program or other funding mechanisms, can be more effectively designed.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    280 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Inflammation and the Host Response to Injury
    Study Start Date :
    Apr 1, 2004
    Actual Primary Completion Date :
    Sep 1, 2013
    Actual Study Completion Date :
    Sep 1, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Time to death [Within two years of burn injury]

    2. Change in gene expression after burn injury [Up to two years after burn injury]

    3. Number and type of complications [Up to two years after burn injury]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Burn patients of all ages with 20% or greater of total body surface area burns that require surgical treatment

    • Burn patients admitted to the burn unit within 96 hours (4 days) of burn injury

    All patients meeting these criteria are entered into the epidemiologic database and assessed for specific exclusion criteria to establish whether serial blood draws are warranted.

    Exclusion Criteria:
    • Injury caused by chemical agent

    • Deep injury caused by conduction of electrical current or charge

    • Decision not to treat due to severity of injury

    • Anoxic brain injury that is not expected to result in complete recovery

    • Associated multiple injuries exclusive of burns (ISS >=25)

    • Pre-morbid condition: Severe congestive heart failure (measured ejection fraction <20%)

    • Pre-morbid condition: Malignancy currently under treatment

    • Pre-morbid condition: Medical condition requiring systemic glucocorticoid treatment

    • Pre-morbid condition: current systemic immunosuppression for organ transplant or chronic inflammatory condition

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Loyola University Medical Center at Loyola in Chicago Maywood Illinois United States 60153
    2 Southwestern Medical Center at University of Texas Southwestern Dallas Texas United States 75390
    3 University of Texas at Galveston-Shriners Burn Hospital- Galveston Galveston Texas United States 77550
    4 Harborview Medical Center at University of Washington Seattle Washington United States 98104

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: Ronald G. Tompkins, MD, ScD, Massachusetts General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Ronald G. Tompkins, Chief, Burns Service, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT00257244
    Other Study ID Numbers:
    • 2 U54 GM062119_burn
    • U54GM062119
    First Posted:
    Nov 22, 2005
    Last Update Posted:
    Mar 7, 2019
    Last Verified:
    Mar 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Ronald G. Tompkins, Chief, Burns Service, Massachusetts General Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 7, 2019